Chennareddy, Susmita
Kalagara, Roshini
Smith, Colton
Matsoukas, Stavros
Bhimani, Abhiraj
Liang, John
Shapiro, Steven
De Leacy, Reade
Mokin, Maxim
Fifi, Johanna T.
Mocco, J
Kellner, Christopher P.
Article History
Received: 8 February 2022
Accepted: 13 May 2022
First Online: 16 June 2022
Declarations
:
: Not applicable.
: Not applicable.
: Dr. De Leacy is a consultant for Stryker, Penumbra, Siemens, and Cerenovus. Dr. Mokin is supported by a grant from the NIH (NIH R21NS109575) and is a consultant for Medtronic and Cerenovus. Additionally, Dr. Mokin is an investor in BrainQ, Endostream, Serenity medical, Synchron. Dr. Fifi is a stockholder in Cerebrotech. Dr. Mocco is the PI on research trials funded by: Stryker Neurovascular, Microvention, and Penumbra and he is an investor in: Cerebrotech, Imperative Care, Endostream, Viseon, BlinkTBI, Myra Medical, Serenity, Vastrax, NTI, RIST, Viz.ai, Synchron, Radical, and Truvic. He serves, or has recently served, as a consultant for: Cerebrotech, Viseon, Endostream, Vastrax, RIST, Synchron, Viz.ai, Perflow, and CVAid. Dr. Kellner has received research grant support from Cerebrotech, Siemens, Penumbra, Minnetronix, Viz.AI, Integra, Longeviti, and Irras and has ownership in Metis Innovative and Precision Recovery. The remaining authors have no conflicts of interest to declare.